HbA1c (glycated hemoglobin) is a well-established long-term blood glucose marker reflecting average glucose levels over 2–3 months. In gut health research, HbA1c serves as an indirect indicator of the microbiome's metabolic influence. Certain gut bacteria produce short-chain fatty acids (e.g., butyrate) that can improve insulin sensitivity and thereby lower HbA1c. Conversely, a dysbiotic gut flora is linked to increased intestinal permeability and systemic inflammation, which may impair glucose regulation and raise HbA1c. However, the evidence is largely observational (human-moderate). Causal relationships remain unclear, and HbA1c is not a direct measure of gut health. A normal HbA1c does not rule out gut dysbiosis. Consumer tests linking HbA1c to gut health should be viewed critically—they provide at best complementary hints, not diagnoses. Comprehensive assessment requires clinical parameters (stool tests, inflammatory markers) and medical guidance.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-6b15a7cf3eca4dd93b421d8e